Organogenesis Holdings ORGO
NASDAQ ORGO
$1.40 +0.03 (+2.19%)
As of: Oct 1, 2026 · 10:05 AM EDT

Organogenesis Holdings (ORGO) Current Deferred Revenue (2025)

Updated

Organogenesis Holdings (ORGO) posted Current Deferred Revenue of $3.86 million for Q4 2025, down 12.2% from the prior quarter.

Analysis

Organogenesis Holdings (ORGO) Current Deferred Revenue (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Organogenesis Holdings 176.28 Mn -118.62 Mn 20.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.86 Mn
Sep 30, 2025 4.40 Mn
Jun 30, 2025 4.77 Mn
API Access

Organogenesis Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ORGO&period=max&api_key=YOUR_API_KEY